Missing/wrong data?
Log in to edit
Targeting regulatory T cells with Interleukin-2 treatment in type 1 diabetes: a response-adaptive, non-randomised, open-label trial of repeat doses of Aldesleukin (DILfrequency)
Author/s
author: Neil M Walker, Mark L. Evans, John A. Todd, Linda S Wicker, Frank D Waldron-Lynch, Linsey Porter, Jane Kennet, Katerina Anselmiova
Work details
Publication date
November 28, 2017
-
-
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.